← All investors

The Column Group

Accelerator🇺🇸 United States

Investment thesis

Science-driven firm with deep fundamental scientific principles, primarily focused on company formation via an 'edge-to-edge' model with the financial wherewithal for long-term private and public support. Backs scientifically-driven teams making big, innovative leaps toward therapeutic breakthroughs.

Notable portfolio

NGM BiopharmaceuticalsNurix Therapeutics

Sector focus

BiotechTherapeuticsLife sciences